Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Robert Huisden"'
Autor:
Peter Schmid, Zbigniew Nowecki, Seock-Ah Im, Wei-Pang Chung, Simon Lord, Anne Armstrong, Cynthia X Ma, Robert Huisden, Ross Stewart, Rakesh Kumar, Gaia Schiavon, Hannah Dry, Ana Nunes, Kyung Hae Jung, Yeon Hee Park
Publikováno v:
Cancer Research. 82:PD10-03
Background: Chemotherapy, together with immune checkpoint inhibitors, improves outcomes vs chemotherapy alone for patients (pts) with metastatic (m)TNBC PD-L1+ disease. Most of these pts progress within a year. In a previous study, D (anti-PD-L1) com
Autor:
Johann de Bono, Christian Poehlein, Allison Allen, Carrie A. Adelman, Jinyu Kang, Julia A. Elvin, Robert Huisden, Alexander Kohlmann, Charles Padua, Young Deuk Choi, Craig Gedye, Nobuaki Matsubara, Mustafa Özgüroǧlu, Guilhem Roubaud, Michael P. Kolinsky, Niven Mehra, David Olmos, Joaquin Mateo, Shahneen Sandhu, Neal Shore, Fred Saad, Karim Fizazi, Caroline Sibilla, Claire Corcoran, Maha Hussain
Supplementary Figure from Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d8c245523421431a9963e0bfaf8fc9
https://doi.org/10.1158/1078-0432.22486373
https://doi.org/10.1158/1078-0432.22486373
Autor:
Johann de Bono, Christian Poehlein, Allison Allen, Carrie A. Adelman, Jinyu Kang, Julia A. Elvin, Robert Huisden, Alexander Kohlmann, Charles Padua, Young Deuk Choi, Craig Gedye, Nobuaki Matsubara, Mustafa Özgüroǧlu, Guilhem Roubaud, Michael P. Kolinsky, Niven Mehra, David Olmos, Joaquin Mateo, Shahneen Sandhu, Neal Shore, Fred Saad, Karim Fizazi, Caroline Sibilla, Claire Corcoran, Maha Hussain
Purpose:Successful implementation of genomic testing in clinical practice is critical for identification of men with metastatic castration-resistant prostate cancer (mCRPC) eligible for olaparib and future molecularly targeted therapies.Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af4a5f059d9d09c98a4b55d79bc2c7e
https://doi.org/10.1158/1078-0432.c.6532301
https://doi.org/10.1158/1078-0432.c.6532301
Autor:
Johann de Bono, Christian Poehlein, Allison Allen, Carrie A. Adelman, Jinyu Kang, Julia A. Elvin, Robert Huisden, Alexander Kohlmann, Charles Padua, Young Deuk Choi, Craig Gedye, Nobuaki Matsubara, Mustafa Özgüroǧlu, Guilhem Roubaud, Michael P. Kolinsky, Niven Mehra, David Olmos, Joaquin Mateo, Shahneen Sandhu, Neal Shore, Fred Saad, Karim Fizazi, Caroline Sibilla, Claire Corcoran, Maha Hussain
Supplementary Data from Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c48c97fd7383dece78bda46f6ef6b73
https://doi.org/10.1158/1078-0432.22486391.v1
https://doi.org/10.1158/1078-0432.22486391.v1
Autor:
Maha Hussain, Claire Corcoran, Caroline Sibilla, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Joaquin Mateo, David Olmos, Niven Mehra, Michael P. Kolinsky, Guilhem Roubaud, Mustafa Özgüroǧlu, Nobuaki Matsubara, Craig Gedye, Young Deuk Choi, Charles Padua, Alexander Kohlmann, Robert Huisden, Julia A. Elvin, Jinyu Kang, Carrie A. Adelman, Allison Allen, Christian Poehlein, Johann de Bono
Publikováno v:
Clinical Cancer Research, 28, 8, pp. 1518-1530
Clinical Cancer Research, 28, 1518-1530
Clinical Cancer Research, 28, 1518-1530
Purpose: Successful implementation of genomic testing in clinical practice is critical for identification of men with metastatic castration-resistant prostate cancer (mCRPC) eligible for olaparib and future molecularly targeted therapies. Patients an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6e6465762b78cfec9e83793e21446e7
https://repository.ubn.ru.nl/handle/2066/249794
https://repository.ubn.ru.nl/handle/2066/249794